Related Experiment Video
Updated: Jul 14, 2026

08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
6.2K
Oocyte Cryopreservation - Current Scenario and Future Perspectives: A Narrative Review
Hrishikesh D Pai1, Rashmi Baid1, Nandita P Palshetkar1
1Department of Reproductive Medicine, Lilavati Hospital and Research Centre, Mumbai, India.
Journal of Human Reproductive Sciences
|February 24, 2022
Summary
Oocyte cryopreservation, particularly vitrification, offers a viable fertility option for women. Preserving 14-20 mature eggs before age 35 is recommended for successful live birth with no increased congenital abnormalities.
Area of Science:
- Reproductive Medicine
- Cryobiology
- Gynecology
Background:
- Oocyte cryopreservation has significantly advanced assisted reproductive technology.
- Indications include fertility preservation for cancer patients, age-related decline, and post-endometriosis surgery.
- Vitrification has become the preferred method over slow freezing.
Purpose of the Study:
- To review clinical applications of oocyte cryopreservation.
- To evaluate ideal age, oocyte number, freezing methods, efficacy, and safety.
- To discuss recent advances in the field.
Main Methods:
- Review of scientific literature on oocyte cryopreservation techniques and outcomes.
- Analysis of data comparing vitrification and slow freezing methods.
- Evaluation of safety and efficacy studies for live birth rates and congenital abnormalities.
Main Results:
- Vitrification is now the dominant cryopreservation technique.
- Optimal age for planned oocyte cryopreservation is early to mid-thirties; younger for diminished ovarian reserve.
- Preserving 14-20 mature oocytes is recommended for successful live birth.
- Fertilization and pregnancy rates are comparable to fresh oocytes.
- No increased incidence of congenital abnormalities observed in babies born from vitrified oocytes.
Conclusions:
- Oocyte cryopreservation, especially via vitrification, is an effective fertility preservation strategy.
- Age and oocyte number are critical factors for successful outcomes.
- Future advancements include AI-driven image analysis and poloscope technology.
More Related Videos
Related Concept Videos
Meiosis II
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each containing...
Oogenesis
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...

